True North is guided by the needs of patients as we discover life-changing medicines for rare diseases. We combine scientific and clinical expertise in diseases of the Complement system so that we can rapidly develop new drugs for rare diseases with few, if any, treatment options. Our R&D is focused on finding novel drugs for rare diseases in which complement is a key driver of pathogenesis. We concentrate on therapies that can intervene upstream in the Complement system, selectively targeting the pathway underlying the disease.
truenorthrx.com
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $142M
Founded date: 2013
Investors 2
| Date | Name | Website |
| - | Perceptive... | perceptive... |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 18.10.2016 | Series D | $45M | - |
| 03.12.2015 | Series C | $40M | - |
| 07.04.2015 | Series B | $35M | - |
| 17.06.2014 | Series A | $22M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 29.12.2016 | Why the complement system is set to shine | Humans also have an innate immune system that, among other things, activates antibodies and tags dub... | medcitynew... |
| 18.10.2016 | True North Therapeutics Closes $45M Series D Financing | True North Therapeutics, a South San Francisco, CA-based clinical stage biotechnology company develo... | finsmes.co... |
| 18.10.2016 | Redmile Group Joins $45M Series D For True North Therapeutic... | True North Therapeutics, a clinical stage biotechnology company developing novel products that selec... | citybizlis... |
| 18.10.2016 | True North Therapeutics raises $45M in Series D toward rare ... | Rare disease focused and early-stage biotech True North Therapeutics (aka TNT) has raised $45 millio... | fiercebiot... |
| 03.12.2015 | True North Therapeutics Raises $40M | SOUTH SAN FRANCISCO, CA, True North Therapeutics announced today that it has completed a $40 milli... | vcnewsdail... |
| 03.12.2015 | True North Therapeutics Completes $40M Series C Equity Finan... | True North Therapeutics, a South San Francisco, CA-based biotechnology company developing novel ther... | finsmes.co... |
| 03.12.2015 | Daily funding roundup - Dec. 3, 2015 | True North Therapeutics bagged $40M; Allocadia raised $16.5M; Younity received $8M funding Younity,... | vator.tv/n... |
| 03.12.2015 | True North Therapeutics gets $40M new approach to autoimmune... | True North is developing antibody drugs that work by inhibiting the complement system to prevent the... | medcitynew... |
| 07.04.2015 | True North Therapeutics Inks $35M Series B | SOUTH SAN FRANCISCO, CA, Biotechnology company developing novel therapies that selectively inhibit... | vcnewsdail... |
| 07.04.2015 | True North Therapeutics Completes $35M Series B Equity Finan... | True North Therapeutics, a South San Francisco, California-based biotechnology company developing no... | finsmes.co... |
Show more